Grants Available for Early-Career Scientists Focusing on Type 1 Diabetes

Diabetes Research Connection announces grants ranging from $25,000 to $50,000 for early-career scientists focused on type 1 diabetes research from those seeing funding for research aimed at finding a cure, prevention, and treatments.

 

Diabetes Research Connection (DRC), a 501(c)(3) that connects early-career scientists and donors to fund research projects aimed at prevention, cure, and better care for those with type 1 diabetes, is accepting letters of intent (LOIs) through August 31 for research grants ranging from $25,000 – $50,000.

To apply, researchers submit a one-page LOI here that is reviewed by DRC’s Scientific Review Committee (SRC). If the concept is approved, the applicant is invited to submit a three-page grant application. U.S.-based post-doctoral fellows, professors, and instructors whose research is focused on type 1 diabetes and have not received NIH funding as a Principal Investigator (PI), are eligible regardless of pre- or post-doctoral fellowships, Career Development Awards (including NIH K-series) or PI listings on an awarded research gift agreement.

“Each application is vetted by DRC’s specialty advisory panel of diabetes experts from around the country,” says DRC scientific director chair Vincenzo Circulli, MD, PhD. “If the project meets our criteria for feasibility and potential impact, it moves on. The entire scientific review process takes about 12 weeks. Our scientific advisors and staff are committed to identifying groundbreaking type 1 diabetes research projects to support.”

DRC executive director Karen Hooper adds, “Our mission is to fund innovative research led by early-stage scientists that has the highest scientific merit and greatest potential for success. About 40,000 people, many of them children, are diagnosed with type 1 diabetes every year. Yet funding for type 1 diabetes research has steadily decreased,” says Hooper. “We believe early-career scientists have a lot to offer type 1 diabetes research and DRC raises funds to support their research aimed at finding viable treatments and a possible cure for type 1 diabetes.”

Sangeeta Dhawan from City of Hope says working with DRC on her project: “Making More and Better Insulin Producing Cells” was gratifying and helpful to attracting future funding as well.

“DRC provided incredible support, reviews, and feedback. Comments on my pre-proposal helped me refine my experimental plan and input provided by the layperson committee enabled me to produce a stronger proposal,” Dhawan says. “And it was one of the fastest reviews of my career!”

Grant LOI submission instructions and key requirements can be found at DRC’s Submit a Project page. Scientists applying for funding will be notified about the status of their application by December 31. For details visit FAQs for Applicants and research projects successfully funded by DRC.

About DRC

The Diabetes Research Connection was established in 2012 by five tireless proponents of diabetes research with a mission to connect motivated donors with early-career scientists and enable novel, peer-reviewed research to find ways to prevent, cure, and treat type 1 diabetes and improve the life of those living with the disease. For more information – www.diabetesresearchconnection.org.

 

 

You may also like

  • FDA Clears AI-Based Type 2 Diabetes Clinical Decision Support System

    In October, DreaMed Diabetes AI LTD. announced that it received its fourth U.S. Food and Drug Administration (FDA) clearance for its Advisor Pro AI Clinical Decision Support System, which expands the platform’s target population to patients with both type 1 and type 2 diabetes. Advisor Pro is a decision support system cleared to assist healthcare providers…

  • Gap in Diabetes Technology Use Among Black and White Medicare Beneficiaries is Worsening

    The gap in the use of insulin pumps and continuous glucose monitors (CGMs) among Black and white Medicare beneficiaries widened from 2017 to 2019, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Reducing health disparities is a major public health goal in the U.S., and these disparities include the use of diabetes technology. All Medicare beneficiaries with type 1 diabetes…

Find more in